Cynthia Villar contracts COVID-19 | Inquirer

Cynthia Villar contracts COVID-19

By: - Reporter /
/ 03:38 PM August 09, 2022

UPDATED MANILA, Philippines — Senator Cynthia Villar has been infected with COVID-19, Senate President Juan Miguel Zubiri announced on Tuesday.

“We just like to put on record that our distinguished colleague, Senator Cynthia Villar, had tested positive today for COVID-19,” Zubiri said during the plenary session.

Article continues after this advertisement

“We would like to wish her well and pray for a speedy recovery and for all our members also to be extra careful at this time when COVID is still surging,” he added.

FEATURED STORIES

Villar is the third senator to get hit by COVID-19.

Last week, Senator Alan Peter Cayetano first tested positive for SARS-CoV-2, the virus that causes COVID-19.

Article continues after this advertisement

As a follow-up, he will be given another test for COVID-19 on Wednesday to confirm if he has recovered from it.

Article continues after this advertisement

Likewise, Senator Imee Marcos is under quarantine and is experiencing a “raging fever,” according to Zubiri on Monday.

The Senate has implemented tighter protocols to limit visitors at the upper chamber in Pasay City.

Starting August 8, visitors are required to present their vaccination card and a negative COVID-19 antigen or reverse transcription-polymerase chain reaction test.

JMS/abc
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

entertainment
business
globalnation
opinion
business
TAGS: Imee Marcos

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.